Summary: Findings support the theory that microRNAs are essential for the development and evolution of intelligent life.
Source: Dartmouth College.
Octopuses have captured the attention of scientists and the public with their remarkable intelligence, including the use of tools, engaging in creative play and problem-solving, and even escaping from aquariums.
Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD
TruDiagnostic Discount Link (Epigenetic Testing)
CONQUERAGING!
https://bit.ly/3Rken0n.
Bristle Discount Link (Oral Microbiome Quantification):
ConquerAging15
https://www.bmq30trk.com/4FL3LK/GTSC3/
Quantify Discount Link (At-Home Blood Testing):
https://getquantify.io/mlustgarten.
Cronometer Discount Link (Daily Diet Tracking):
https://shareasale.com/r.cfm?b=1390137&u=3266601&m=61121&urllink=&afftrack=
If you’d like to support the channel, you can do that with the website.
Biophysist and Biochemist Dr. Maximilian Plach talks about a groundbreaking new technology for editing genes, called CRISPR-Cas9. The tool allows scientists to make precise edits to DNA strands, which could lead to treatments for genetic diseases … but could also be used to create so-called “designer babies.” Max reviews how CRISPR-Cas9 works — and asks the scientific community to pause and discuss the ethics of this new tool. Max has earned his PhD in biophysics and computational biology at the University of Regensburg, Germany. He is now Chief Scientific Officer of 2bind, a dynamic and growing company focused on providing biophysical research services for biotech and pharma industries. It is therefore no wonder that Max closely follows the latest breakthroughs and developments in biotech and biomedical technology. He is a long viewer and listener of TED talks; the more exotic, the better. Or who doesn’t remember the talk about the world’s worst city flags? This talk was given at a TEDx event using the TED conference format but independently organized by a local community.
Aging remains a primary risk factor for a host of diseases, including leading causes of death. Aging and associated diseases are inherently multifactorial, with numerous contributing factors and phenotypes at the molecular, cellular, tissue, and organismal scales. Despite the complexity of aging phenomena, models currently used in aging research possess limitations. Frequently used in vivo models often have important physiological differences, age at different rates, or are genetically engineered to match late disease phenotypes rather than early causes. Conversely, routinely used in vitro models lack the complex tissue-scale and systemic cues that are disrupted in aging.
A study published Wednesday in the JAMA Psychiatry journal shows that four key genetic variations are more common in military veterans who have taken their own life or considered it.
Scientists from Duke University in Durham, North Carolina, found the pattern while analyzing blood samples from a database that included 633,778 U.S. veterans, cross-referenced with the International Suicide Genetics Consortium of more than 549,000 individuals.
The obtained samples were sequenced to create genetic profiles compared to participants’ medical records, showing that 121,211 recorded cases of attempted suicide or thoughts about killing themselves.
Year 2020 face_with_colon_three
Scientists are working to end the need for human heart transplants by 2028. A team of researchers in the UK, Cambridge, and the Netherlands are developing a robot heart that can pump blood through the circulatory network but is soft and pliable. The first working model should be ready for implantation into animals within the next 3 years, and into humans within the next 8 years. The device is so promising that it is among just 4 projects that have made it to the shortlist for a £30-million prize, called the Big Beat Challenge for a therapy that can change the game in the treatment of heart disease.
The other projects include a genetic therapy for heart defects, a vaccine against heart disease, and wearable technology for early preclinical detection of heart attacks and strokes.
The need
There are about 7 million patients with heart and circulatory issues in the UK of which over 150,000 die every year. About 200 heart transplants occur each year in the UK alone, yet about 20 patients die in the same period while waiting for one. This is especially true if the patient waiting for one is a baby who was born with a defective heart, since babies need to have hearts transplanted from other babies – who must have died. And even with a successful transplant, strong immunosuppressive drugs must be started and often continued lifelong so that immune rejection does not occur. This is, however, accompanied by a higher risk of infectious and other complications.
In the underground movement known as, people are taking their health into their own hands. Biohacking ranges from people making simple lifestyle changes to extreme body modifications.
One popular form of focuses on nutrigenomics, where biohackers study how the foods they eat affect their genes over time. They believe they can map and track the way their diet affects genetic function. They use dietary restrictions and blood tests, while tracking their moods, energy levels, behaviors, and cognitive abilities.
Then there are grinders, a subculture of A grinder believes there’s a hack for every part of the body. Rather than attempting to modify our existing biology, grinders seek to enhance it with implanted technology.
Huntington’s disease (HD) is a neurological disorder that causes progressive loss of movement, coordination and cognitive function. It is caused by a mutation in a single gene called huntingtin (HTT). More than 200,000 people worldwide live with the genetic condition, approximately 30,000 in the United States. More than a quarter of a million Americans are at risk of inheriting HD from an affected parent. There is no cure.
But in a new study, published December 12, 2022 in Nature Neuroscience, researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe using RNA-targeting CRISPR/Cas13D technology to develop a new therapeutic strategy that specifically eliminates toxic RNA that causes HD.
CRISPR is known as a genome-editing tool that allows scientists to add, remove or alter genetic material at specific locations in the genome. It is based on a naturally occurring immune defense system used by bacteria. However, current strategies run the risk of off-target edits at unintended sites that may cause permanent and inheritable chromosomal insertions or genome alterations. Because of this, significant efforts have focused on identifying CRISPR systems that target RNA directly without altering the genome.